Capricor Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.11.24	Decoding 12 Analyst Evaluations For Capricor Therapeutics (Benzinga)
12.11.24	Earnings Preview For Capricor Therapeutics (Benzinga)
17.10.24	Why Capricor Therapeutics (CAPR) Shares Are Trading Lower (Benzinga)
11.10.24	Capricor Therapeutics Says Duchenne Muscular Dystrophy Candidate Shows Sustained Cardiac, Skeletal Benefits After 3 Years (Benzinga)
09.10.24	Forecasting The Future: 9 Analyst Projections For Capricor Therapeutics (Benzinga)
30.09.24	Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today (Benzinga)
25.09.24	Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
24.09.24	Why Capricor Therapeutics Stock Is Soaring Tuesday (Benzinga)
20.09.24	Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings) (Benzinga)
17.09.24	EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm (Benzinga)
02.07.24	Unveiling 6 Analyst Insights On Capricor Therapeutics (Benzinga)
28.06.24	What's Going On With Capricor Therapeutics Stock Friday? (Benzinga)
11.06.24	What's Going On With Capricor Therapeutics Stock Tuesday? (Benzinga)
04.06.24	What's Going On With Capricor Therapeutics Stock Tuesday? (Benzinga)
14.05.24	Expert Ratings For Capricor Therapeutics (Benzinga)
29.02.24	Recap: Capricor Therapeutics Q4 Earnings (Benzinga)
26.03.19	Ausblick: Capricor Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
11.11.18	Ausblick: Capricor Therapeutics veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
14.02.18	Metro Phoenix Bank Reports Earnings of $417,000, or $0.11 per Diluted Share in 4Q2017 and Efficiency Ratio of 50.53% (PR Newswire)
13.12.17	Capricor Therapeutics Announces Issuance of Key U.S. Patent on Exosome Technology (PR Newswire)
29.11.17	Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002 (PR Newswire)
22.11.17	Capricor Therapeutics to Present at the Piper Jaffray Healthcare Conference (PR Newswire)
15.11.17	Significant Improvements Reported in Duchenne Muscular Dystrophy Patients Treated with Capricor's Investigational Cell Therapy (PR Newswire)
09.11.17	OTIC Data Music To Ears, Apellis IPO Opens Today, CAPR High On HOPE (RTTNews)
08.11.17	Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Duchenne Muscular Dystrophy Development Program (PR Newswire)
01.11.17	Capricor Therapeutics Third Quarter 2017 Update Webcast and Conference Call Scheduled for Wednesday, November 8 (PR Newswire)
06.10.17	Capricor Therapeutics Reports Intravenous Administration of CAP-1002 Shown to be Effective in Preclinical Models of Duchenne Muscular Dystrophy (PR Newswire)
04.10.17	Capricor Therapeutics Presents Positive Six-Month Results in Duchenne Muscular Dystrophy at World Muscle Society International Congress (PR Newswire)
26.09.17	Capricor Therapeutics Advances Clinical Development Program in Duchenne Muscular Dystrophy with Naming of Principal Investigator (PR Newswire)
20.09.17	CAPR Is Hot, VBLT In Rally Mode, MYOK's Data Heartening, MediWound Bleeds (RTTNews)
18.09.17	Capricor Therapeutics to Present Six-Month Results from the Randomized HOPE Trial of CAP-1002 in Duchenne Muscular Dystrophy in a Late Breaking Session of the World Muscle Society (PR Newswire)
14.09.17	ESC Silicon Valley 2017 Announces Full Conference Schedule, Keynote Speakers (PR Newswire)
10.08.17	Capricor Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
08.08.17	Breakfast Technical Briefing on Biotech Stocks -- CytRx, Aeterna Zentaris, Capricor Therapeutics, and Cymabay Therapeutics (PR Newswire)
03.08.17	Capricor Therapeutics Second Quarter 2017 Update Webcast and Conference Call Scheduled for Thursday, August 10 (PR Newswire)
28.07.17	The Big Deal About Stem Cell Therapies and Regenerative Medicine (PR Newswire)
28.07.17	The Big Deal About Stem Cell Therapies and Regenerative Medicine (PR Newswire)
28.07.17	Gainers & Losers Of July 27: CAPR, ANIK, MMSI, AZN, TTPH, AGEN... (RTTNews)
27.07.17	Capricor Announces Results of FDA Meeting on Intravenous CAP-1002 for Duchenne Muscular Dystrophy (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
21.07.17	Congress Could Have Major Impact on Biotech Companies (PR Newswire)
19.07.17	Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH... (RTTNews)
18.07.17	Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients with Duchenne Muscular Dystrophy (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Capricor Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten